Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. AstraZeneca PLC
  6. News
  7. Summary
    AZN   GB0009895292

ASTRAZENECA PLC

(AZN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

AstraZeneca to Build $360 Million Manufacturing Plant in Dublin

09/21/2021 | 12:23am EDT

By Jaime Llinares Taboada

AstraZeneca PLC said Tuesday that it will invest $360 million in a manufacturing facility in Ireland.

The pharmaceutical company said it is planning to build an active pharmaceutical ingredient-manufacturing facility for small molecules near Dublin to ensure that its supply network is fit for future growth.

The plant will allow for late-stage development and early commercial supply, AstraZeneca said. It will create 100 direct jobs and further indirect jobs.

Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT

(END) Dow Jones Newswires

09-21-21 0223ET

All news about ASTRAZENECA PLC
10/27VACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
RE
10/26ASTRAZENECA : Deutsche Bank reiterates its Buy rating
MD
10/26VACCINATED BUT STUCK : Indians await WHO nod for homegrown shot to travel abroad
RE
10/25AstraZeneca PLC Announces Positive High-Level Results from the TOPAZ-1 Phase III Trial
CI
10/25ASTRAZENECA : Daiichi Sankyo in Clinical Trial Collaboration to Evaluate Datopotamab Derux..
MT
10/25WALL STREET STOCK EXCHANGE : 84% of Q3 earnings reports exceed expectations
10/25ANALYST RECOMMENDATIONS : American Express, Beyond Meat, Microsoft, Oracle, Weibo...
10/25UNIVERSITY OF BIRMINGHAM : A third of leukaemia patients do not generate any antibody resp..
AQ
10/25ASTRAZENECA : Imfinzi plus chemotherapy significantly improved overall survival in 1st-lin..
AQ
10/25ASTRAZENECA : JP Morgan reiterates its Buy rating
MD
More news
Analyst Recommendations on ASTRAZENECA PLC
More recommendations
Financials (USD)
Sales 2021 35 441 M - -
Net income 2021 4 862 M - -
Net Debt 2021 24 715 M - -
P/E ratio 2021 35,7x
Yield 2021 2,28%
Capitalization 191 B 191 B -
EV / Sales 2021 6,10x
EV / Sales 2022 4,93x
Nbr of Employees 76 100
Free-Float 96,4%
Chart ASTRAZENECA PLC
Duration : Period :
AstraZeneca PLC Technical Analysis Chart | AZN | GB0009895292 | MarketScreener
Technical analysis trends ASTRAZENECA PLC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 27
Last Close Price 123,49 $
Average target price 137,83 $
Spread / Average Target 11,6%
EPS Revisions
Managers and Directors
Pascal Soriot Chief Executive Officer & Executive Director
Aradhana Sarin Chief Financial Officer & Executive Director
Leif Valdemar Johansson Non-Executive Chairman
Menelas NICOLAS Pangalos EVP-Biopharmaceuticals Research & Development
Pam P. Cheng Executive VP-Operations & Information Technology
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PLC22.80%191 297
JOHNSON & JOHNSON4.04%436 334
ROCHE HOLDING AG15.84%338 387
NOVO NORDISK A/S60.69%244 467
PFIZER, INC.18.34%244 227
ELI LILLY AND COMPANY48.17%225 231